Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 114OTHER_GOV 2NETWORK 2

Study Type

Observational 2

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 2Breast Neoplasms 2Syndrome 1Salivary Gland Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Pain 1Disease 1Depression 1Colorectal Neoplasms 1Chronic Pain 1COVID-19 1Anxiety Disorders 1Acute Pain 1

Interventions

Drug Therapy 4pembrolizumab 3Thermography 2Surveys and Questionnaires 2Standard of Care 2Quality of Life 2Preoperative Exercise 2Nivolumab 2Moxibustion 2Hematologic Tests 2Cyclophosphamide 2Chemoradiotherapy 2vandetanib 1sinovac COVID-19 vaccine 1lenvatinib 1ibrutinib 1fludarabine 1encorafenib 1durvalumab 1binimetinib 1beta Carotene 1avelumab 1atezolizumab 1Zoledronic Acid 1Zinc 1Vitamin E 1Vascular Access Devices 1Validation Studies as Topic 1Urination 1Ultraviolet Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Neoplasms × Surveys and Questionnaires × Clear all
NCT04382495 2024-08-28

The Impact of COVID-19 Pandemic on Cancer Care

El Zaitoun Specialized Hospital

Completed
300 enrolled

COVID-19, Neoplasms

NCT02775825 2016-05-19

Quality of the End of Life Care

National Guard Health Affairs

Completed
180 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡